Real-world data for efficient health technology assessment

被引：15

作者：

Hall, Peter S. ^{[1
]}

机构：

[1] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland

来源：

EUROPEAN JOURNAL OF CANCER | 2017年 / 79卷

关键词：

D O I：

10.1016/j.ejca.2017.04.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：235 / 237

页数：3

共 8 条

[1] Modeling Good Research Practices-Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 [J].

Caro, J. Jaime ;

Briggs, Andrew H. ;

Siebert, Uwe ;

Kuntz, Karen M. .

MEDICAL DECISION MAKING, 2012, 32 (05) :667-677

[2]

Freemantle N, 2013, BMJ-BRIT MED J, P347

[3] Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report [J].

Garrison, Louis P., Jr. ;

Neumann, Peter J. ;

Erickson, Pennifer ;

Marshall, Deborah ;

Mullins, Daniel .

VALUE IN HEALTH, 2007, 10 (05) :326-335

[4]

McCabe C, 2013, LEASING HLTH TECHNOL

[5] Principles of Design of Access with Evidence Development Approaches A Consensus Statement from the Banff Summit [J].

Menon, Devidas ;

McCabe, Christopher J. ;

Stafinski, Tania ;

Edlin, Richard .

PHARMACOECONOMICS, 2010, 28 (02) :109-111

[6]

National Institute for Health and Care Excellence (NICE), 2013, Guide to the methods of technology appraisal 2013

[7] The Strength of Association Between Surrogate End Points and Survival in Oncology A Systematic Review of Trial-Level Meta-analyses [J].

Prasad, Vinay ;

Kim, Chul ;

Burotto, Mauricio ;

Vandross, Andrae .

JAMA INTERNAL MEDICINE, 2015, 175 (08) :1389-1398

[8] Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium [J].

van Kampen, R. J. W. ;

Ramaekers, B. L. T. ;

Lobbezoo, D. J. A. ;

de Boer, M. ;

Dercksen, M. W. ;

van den Berkmortel, F. ;

Smilde, T. J. ;

van de Wouw, A. J. ;

Peters, F. P. J. ;

van Riel, J. M. G. ;

Peters, N. A. J. B. ;

Tjan-Heijnen, V. C. G. ;

Joore, M. A. .

EUROPEAN JOURNAL OF CANCER, 2017, 79 :238-246

← 1 →